Microtubule and microtubule associated protein anomalies in psychiatric disease

Cytoskeleton

Volumn 73, Issue 10, 2016, Pages 596-611

  Marchisella, Francesca ^a   Coffey, Eleanor T ^a   Hollos, Patrik ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

depression; JNK; MAP2; microtubule; schizophrenia

Indexed keywords

BETA TUBULIN; DIHYDROPYRIMIDINASE; DIZOCILPINE; FLUOXETINE; GLUTAMATE RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE 6; KETAMINE; LITHIUM; MELATONIN; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN NEUROSTEROID PREGNENOLONE; NEUROSTEROID; SIRTUIN 2; STABLE TUBULE ONLY POLYPEPTIDE; STRESS ACTIVATED PROTEIN KINASE 1; TUBULIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BIPOLAR DISORDER; CYTOSKELETON; DEACETYLATION; DEPRESSION; DETYROSINATION; DISRUPTED IN SCHIZOPHRENIA 1 GENE; GENE; GENETIC LINKAGE; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; MENTAL DISEASE; MENTAL STRESS; MICROTUBULE; MOOD DISORDER; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; POLYGLYCYLATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SCHIZOPHRENIA; SLEEP DISORDER; TPPP GENE; TREATMENT RESISTANT DEPRESSION; TYROSINATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BIPOLAR DISORDER; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SCHIZOPHRENIA; TUBULIN;

EID: 84970965915     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.21300     Document Type: Review

References (187)

1. Ainsztein AM, Purich DL. 1994. Stimulation of tubulin polymerization by MAP-2. Control by protein kinase C-mediated phosphorylation at specific sites in the microtubule-binding region. J Biol Chem 269:28465–28471.
2. Ait-Belkacem R, Calligaris D, Sellami L, Villard C, Granjeaud S, Schembri T, Berenguer C, Ouafik L, Figarella-Branger D, Chinot O, et al. 2013. Tubulin isoforms identified in the brain by MALDI in-source decay. J Proteomics 79:172–179.
3. Al-Bassam J, Ozer RS, Safer D, Halpain S, Milligan RA. 2002. MAP2 and tau bind longitudinally along the outer ridges of microtubule protofilaments. J Cell Biol 157:1187–1196.
4. Alexa A, Schmidt G, Tompa P, Ogueta S, Vázquez J, Kulcsár P, Kovács J, Dombrádi V, Friedrich P. 2002. The phosphorylation state of threonine-220, a uniquely phosphatase-sensitive protein kinase A site in microtubule-associated protein MAP2c, regulates microtubule binding and stability. Biochemistry 41:12427–12435.
5. Alexander JE, Hunt DF, Lee MK, Shabanowitz J, Michel H, Berlin SC, MacDonald TL, Sundberg RJ, Rebhun LI, Frankfurter A. 1991. Characterization of posttranslational modifications in neuron-specific class III beta-tubulin by mass spectrometry. Proc Natl Acad Sci U S A 88:4685–4689.
6. Arnold SE, Lee VM, Gur RE, Trojanowski JQ. 1991. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci U S A 88:10850–10854.
7. Baird FJ, Bennett CL. 2013. Microtubule defects & Neurodegeneration. J Genet Syndr Gene Ther 4:203–203. (Figure 1):
8. Baptista J, Mercer C, Prigmore E, Gribble SM, Carter NP, Maloney V, Thomas NS, Jacobs PA, Crolla JA. 2008. Breakpoint mapping and array CGH in translocations: comparison of a phenotypically normal and an abnormal cohort. Am J Hum Genet 82:927–936.
9. Baron M. 2002. Manic-depression genes and the new millennium: poised for discovery. Mol Psychiatry 7:342–358.
10. Baulieu EE, Schumacher M. 1997. Neurosteroids, with special reference to the effect of progesterone on myelination in peripheral nerves. Mult Scler 3:105–112.
11. Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. 2006. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6:3414–3425.
12. Belmaker RH, Agam G. 2008. Major depressive disorder. N Engl J Med 358:55–68.
13. Benítez-King G. 2006. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 40:1–9.
14. Berling B, Wille H, Roll B, Mandelkow EM, Garner C, Mandelkow E. 1994. Phosphorylation of microtubule-associated proteins MAP2a,b and MAP2c at Ser136 by proline-directed kinases in vivo and in vitro. Eur J Cell Biol 64:120–130.
15. Beurel E, Song L, Jope RS. 2011. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 16:1068–1070.
16. Bianchi M, Baulieu EE. 2012. 3beta-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders. Proc Natl Acad Sci U S A 109:1713–1718.
17. Bianchi M, Heidbreder C, Crespi F. 2003. Cytoskeletal changes in the hippocampus following restraint stress: role of serotonin and microtubules. Synapse 49:188–194.
18. Bianchi M, Shah AJ, Fone KC, Atkins AR, Dawson LA, Heidbreder CA, Hows ME, Hagan JJ, Marsden CA. 2009. Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus. Synapse 63:359–364.
19. Bjorkblom B, Ostman N, Hongisto V, Komarovski V, Filen JJ, Nyman TA, Kallunki T, Courtney MJ, Coffey ET. 2005. Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J Neurosci 25:6350–6361.
20. Black MM, Baas PW. 1989. The basis of polarity in neurons. Trends Neurosci 12:211–214.
21. Blanpied TA, Ehlers MD. 2004. Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease. Biol Psychiatry 55:1121–1127.
22. Bosc C, Cronk JD, Pirollet F, Watterson DM, Haiech J, Job D, Margolis RL. 1996. Cloning, expression, and properties of the microtubule-stabilizing protein STOP. Proc Natl Acad Sci U S A 93:2125–2130.
23. Bosc C, Andrieux A, Job D. 2003. STOP proteins. Biochemistry 42:12125–12132.
24. Bouras C, Kövari E, Hof PR, Riederer BM, Giannakopoulos P. 2001. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol 102:373–379.
25. Brenner E, Sonnewald U, Schweitzer A, Andrieux A, Nehlig A. 2007. Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia. J Neurosci Res 85:3487–3493.
26. Broadbelt K, Byne W, Jones LB. 2002. Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res 58:75–81.
27. Brown AS, Borgmann-Winter K, Hahn CG, Role L, Talmage D, Gur R, Chow J, Prado P, McCloskey T, Bao Y, et al. 2014. Increased stability of microtubules in cultured olfactory neuroepithelial cells from individuals with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 48:252–258.
28. Browne CA, Lucki I. 2013. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol 4:161.
29. Bélanger D, Farah CA, Nguyen MD, Lauzon M, Cornibert S, Leclerc N. 2002. The projection domain of MAP2b regulates microtubule protrusion and process formation in Sf9 cells. J Cell Sci 115:1523–1539.
30. Caceres A, Mautino J, Kosik KS. 1992. Suppression of MAP2 in cultured cerebellar macroneurons inhibits minor neurite formation. Neuron 9:607–618.
31. Cardinali DP, Furio AM, Brusco LI. 2010. Clinical aspects of melatonin intervention in Alzheimer's disease progression. Curr Neuropharmacol 8:218–227.
32. Cardounel A, Regelson W, Kalimi M. 1999. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc Soc Exp Biol Med 222:145–149.
33. Chang L, Jones Y, Ellisman MH, Goldstein LS, Karin M. 2003. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell 4:521–533.
34. Chen J, Kanai Y, Cowan NJ, Hirokawa N. 1992. Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature 360:674–677.
35. Clark L, Watson D. 1991. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnormal Psychol 100:316–336.
36. Cocchi M, Tonello L, Rasenick MM. 2010. Human depression: a new approach in quantitative psychiatry. Ann Gen Psychiatry 9:25.
37. Coffey ET. 2014. Nuclear and cytosolic JNK signalling in neurons. Nat Rev Neurosci 15:285–299.
38. Cole AR. 2013. Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia. Febs J 280:5213–5227.
39. Contreras-Vallejos E, Utreras E, Bórquez DA, Prochazkova M, Terse A, Jaffe H, … González-Billault C. 2014. Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5–/– mice. PloS one 9(3):e90363.
40. Corcoran KA, Leaderbrand K, Jovasevic V, Guedea AL, Kassam F, Radulovic J. 2015. Regulation of fear extinction versus other affective behaviors by discrete cortical scaffolding complexes associated with NR2B and PKA signaling. Transl Psychiatry 5:e657.
41. Corena-McLeod M, Walss-Bass C, Oliveros A, Gordillo Villegas A, Ceballos C, Charlesworth CM, Madden B, Linser PJ, Van Ekeris L, Smith K, et al 2013. New Model of Action for Mood Stabilizers: Phosphoproteome from Rat Pre-Frontal Cortex Synaptoneurosomal Preparations. PLoS ONE 8:1–12.
42. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, et al. 2011. A copy number variation morbidity map of developmental delay. Nat Genet 43:838–846.
43. Davis RJ. 1993. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553–14556.
44. Daoust A, Bohic S, Saoudi Y, Debacker C, Gory-Fauré S, Andrieux A, Barbier EL, Deloulme JC. 2014. Neuronal transport defects of the MAP6 KO mouse - a model of schizophrenia - and alleviation by Epothilone D treatment, as observed using MEMRI. Neuroimage 96:133–142.
45. de Anda FC, Rosario AL, Durak O, Tran T, Gräff J, Meletis K, Rei D, Soda T, Madabhushi R, Ginty DD, et al. 2012. Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex. Nat Neurosci 15:1022–1031.
46. Dehmelt L, Halpain S. 2004. Actin and microtubules in neurite initiation: are MAPs the missing link? J Neurobiol 58:18–33.
47. Doble BW, Woodgett JR. 2003. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175–1186.
48. Drago A, Crisafulli C, Sidoti A, Calabrò M, Serretti A. 2016. The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades. J Affect Disord 190:429–438.
49. Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E. 1997. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89:297–308.
50. Duman EA, Canli T. 2015. Influence of life stress, 5-HTTLPR genotype, and SLC6A4 methylation on gene expression and stress response in healthy Caucasian males. Biol Mood Anxiety Disord 5:2.
51. English Ja Dicker P, Föcking M, Dunn MJ Cotter DR. 2009. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics 9:3368–3382.
52. Fellous A, Francon J, Lennon AM, Nunez J. 1977. Microtubule assembly in vitro. Purification of assembly-promoting factors. Eur J Biochem 78:167–174.
53. Flood JF, Morley JE, Roberts E. 1992. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci U S A 89:1567–1571.
54. Fontaine-Lenoir V, Chambraud B, Fellous A, David S, Duchossoy Y, Baulieu EE, Robel P. 2006. Microtubule-associated protein 2 (MAP2) is a neurosteroid receptor. Proc Natl Acad Sci U S A 103:4711–4716.
55. Fournet V, Jany M, Fabre V, Chali F, Orsal D, Schweitzer A, Andrieux A, Messanvi F, Giros B, Hamon M, et al. 2010. The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. J Neurochem 115:1579–1594.
56. Fournet V, Schweitzer A, Chevarin C, Deloulme JC, Hamon M, Giros B, Andrieux A, Martres MP. 2012. The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances. J Neurochem 121:99–114.
57. Friedrich P, Aszodi A. 1991. MAP2: a sensitive cross-linker and adjustable spacer in dendritic architecture. FEBS Lett 295:5–9.
58. Fuchikami M, Yamamoto S, Morinobu S, Okada S, Yamawaki Y, Yamawaki S. 2015. The potential use of histone deacetylase inhibitors in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry 64:320–324.
59. Fujimoto T, Tanaka H, Kumamaru E, Okamura K, Miki N. 2004. Arc interacts with microtubules/microtubule-associated protein 2 and attenuates microtubule-associated protein 2 immunoreactivity in the dendrites. J Neurosci Res 76:51–63.
60. Fukada M, Hanai A, Nakayama A, Suzuki T, Miyata N, Rodriguiz RM, Wetsel WC, Yao T-P, Kawaguchi Y. 2012. Loss of deacetylation activity of Hdac6 affects emotional behavior in mice. PloS One 7:e30924–e30924.
61. Fukata Y, Kimura T, Kaibuchi K. 2002. Axon specification in hippocampal neurons. Neurosci Res 43:305–315.
62. Fukushima N, Furuta D, Hidaka Y, Moriyama R, Tsujiuchi T. 2009. Post-translational modifications of tubulin in the nervous system. J Neurochem 109:683–693.
63. Fullston T, Gabb B, Callen D, Ullmann R, Woollatt E, Bain S, Ropers HH, Cooper M, Chandler D, Carter K, et al. 2011. Inherited balanced translocation t(9;17)(q33.2;q25.3) concomitant with a 16p13.1 duplication in a patient with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 156:204–214.
64. Gao T, Blackwell R, Glaser MA, Betterton MD, Shelley MJ. 2015. Multiscale polar theory of microtubule and motor-protein assemblies. Phys Rev Lett 114:048101.
65. Garnham CP, Roll-Mecak A. 2012. The chemical complexity of cellular microtubules: tubulin post-translational modification enzymes and their roles in tuning microtubule functions. Cytoskeleton (Hoboken, N.J.) 69:442–463.
66. Gartside SE, Leitch MM, McQuade R, Swarbrick DJ. 2003. Flattening the glucocorticoid rhythm causes changes in hippocampal expression of messenger RNAs coding structural and functional proteins: implications for aging and depression. Neuropsychopharmacology 28:821–829.
67. Glausier JR, Lewis D. 2013. Dendritic spine pathology in schizophrenia. Neuroscience 251:90–107.
68. Głombik K, Stachowicz A, Ślusarczyk J, Trojan E, Budziszewska B, Suski M, Kubera M, Lasoń W, Wędzony K, Olszanecki R, et al. 2015. Maternal stress predicts altered biogenesis and the profile of mitochondrial proteins in the frontal cortex and hippocampus of adult offspring rats. Psychoneuroendocrinology 60:151–162.
69. Gold PW. 2015. The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry 20:32–47.
70. Goldberg Y. 1999. Protein phosphatase 2A: who shall regulate the regulator? Biochem Pharmacol 57:321–328.
71. Goold RG, Owen R, Gordon-Weeks PR. 1999. Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones. J Cell Sci 112:3373–3384.
72. Gozes I. 2011. Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate. Peptides 32:428–431.
73. Grau MB, Curto GG, Rocha C, Magiera MM, Sousa PM, Giordano T, Spassky N, Janke C. 2013. Tubulin glycylases and glutamylases have distinct functions in stabilization and motility of ependymal cilia. J Cell Biol 202:441–451.
74. Greenberger LM, Loganzo F. 2008. The Role of Microtubules in Cell Biology. Neurobiol Oncol 227–258.
75. Grimes CA, Jope RS. 2001. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 78:1219–1232.
76. Guerini D. 1997. Calcineurin: not just a simple protein phosphatase. Biochem Biophys Res Commun 235:271–275.
77. Guo J, Walss-Bass C, Ludueña RF. 2010. The beta isotypes of tubulin in neuronal differentiation. Cytoskeleton (Hoboken) 67:431–441.
78. Gurling HM, Critchley H, Datta SR, McQuillin A, Blaveri E, Thirumalai S, Pimm J, Krasucki R, Kalsi G, Quested D, et al. 2006. Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. Arch Gen Psychiatry 63:844–54.
79. Halpain S, Greengard P. 1990. Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2. Neuron 5:237–246.
80. Hameroff S. 2007. Orchestrated reduction of quantum coherence in brain microtubules: a model for consciousness. Neuroquantology 5:1–8.
81. Harada A, Teng J, Takei Y, Oguchi K, Hirokawa N. 2002. MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J Cell Biol 158:541–549.
82. Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, Ishimoto T, Mori T, Nemoto K, Adachi N, Izumi A, et al. 2006. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 15:3024–3033.
83. Hensley K, Christov A, Kamat S, Zhang XC, Jackson KW, Snow S, Post J. 2010. Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures. J Neurosci 30:2979–2988.
84. Heo YS, Kim SK, Seo CI, Kim YK, Sung BJ, Lee HS, Lee JI, Park SY, Kim JH, Hwang KY, et al. 2004. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. Embo J 23:2185–2195.
85. Hoogenraad CC, Bradke F. 2009. Control of neuronal polarity and plasticity–a renaissance for microtubules? Trends Cell Biol 19:669–676.
86. Horio T, Murata T, Damme DV. 2014. The role of dynamic instability in microtubule organization. Plant Traffic Transport 5:511.
87. Hoshi M, Ohta K, Gotoh Y, Mori A, Murofushi H, Sakai H, Nishida E. 1992. Mitogen-activated-protein-kinase-catalyzed phosphorylation of microtubule-associated proteins, microtubule-associated protein 2 and microtubule-associated protein 4, induces an alteration in their function. Eur J Biochem 203:43–52.
88. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang X-F, Yao T-P. 2002. HDAC6 is a microtubule-associated deacetylase. Nature 417:455–458.
89. Hugdahl JD, Bokros CL, Hanesworth VR, Aalund GR, Morejohn LC. 1993. Unique functional characteristics of the polymerization and MAP binding regulatory domains of plant tubulin. Plant Cell 5:1063–1080.
90. Ikegami K, Heier RL, Taruishi M, Takagi H, Mukai M, Shimma S, Taira S, Hatanaka K, Morone N, Yao I, et al. 2007. Loss of alpha-tubulin polyglutamylation in ROSA22 mice is associated with abnormal targeting of KIF1A and modulated synaptic function. Proc Natl Acad Sci U S A 104:3213–3218.
91. Janke C. 2014. The tubulin code: molecular components, readout mechanisms, and functions. J Cell Biol 206:461–472.
92. Kalcheva N, Albala J, O'Guin K, Rubino H, Garner C, Shafit-Zagardo B. 1995. Genomic structure of human microtubule-associated protein 2 (MAP-2) and characterization of additional MAP-2 isoforms. Proc Natl Acad Sci U S A 92:10894–10898.
93. Kalcheva N, Rockwood JM, Kress Y, Steiner A, Shafit-Zagardo B. 1998. Molecular and functional characteristics of MAP-2a: ability of MAP-2a versus MAP-2b to induce stable microtubules in COS cells. Cell Motil Cytoskeleton 40:272–285.
94. Kalliolia E, Silajdzic E, Nambron R, Hill NR, Doshi A, Frost C, Watt H, Hindmarsh P, Bjorkqvist M, Warner TT. 2014. Plasma melatonin is reduced in Huntington's disease. Mov Disord 29:1511–1515.
95. Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, Jeong LS, Banasr M, et al. 2012. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 18:1413–1417.
96. Kapitein LC, Hoogenraad CC. 2011. Which way to go? Cytoskeletal organization and polarized transport in neurons. Mol Cell Neurosci 46:9–20.
97. Kapitein LC, Yau KW, Gouveia SM, van der Zwan WA, Wulf PS, Keijzer N, Demmers J, Jaworski J, Akhmanova A, Hoogenraad CC. 2011. NMDA receptor activation suppresses microtubule growth and spine entry. J Neurosci 31:8194–8209.
98. Karishma KK, Herbert J. 2002. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 16:445–453.
99. Kaufmann WE, MacDonald SM, Altamura CR. 2000. Dendritic cytoskeletal protein expression in mental retardation: an immunohistochemical study of the neocortex in Rett syndrome. Cereb Cortex 10:992–1004.
100. Kevenaar JT, Hoogenraad CC. 2015. The axonal cytoskeleton: from organization to function. Front Mol Neurosci 8:44.
101. Komulainen E, Zdrojewska J, Freemantle E, Mohammad H, Kulesskaya N, Deshpande P, Marchisella F, Mysore R, Hollos P, Michelsen KA, et al. 2014. JNK1 controls dendritic field size in L2/3 and L5 of the motor cortex, constrains soma size, and influences fine motor coordination. Front Cell Neurosci 8:272.
102. Lang B, Pu J, Hunter I, Liu M, Martin-Granados C, Reilly TJ, Gao G-D, Guan Z-L, Li W-D, Shi Y-Y, et al. 2014. Recurrent deletions of ULK4 in schizophrenia: a gene crucial for neuritogenesis and neuronal motility. J Cell Sci 127:630–640.
103. Law AJ, Weickert CS, Hyde TM, Kleinman JE, Harrison PJ. 2004. Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am J Psychiatry 161:1848–1855.
104. Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frankfurter A. 1990. The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis. Cell Motil Cytoskeleton 17:118–132.
105. Lefèvre J, Savarin P, Gans P, Hamon L, Clément MJ, David MO, Bosc C, Andrieux A, Curmi PA. 2013. Structural basis for the association of MAP6 protein with microtubules and its regulation by calmodulin. J Biol Chem 288:24910–24922.
106. Li R, Gundersen GG. 2008. Beyond polymer polarity: how the cytoskeleton builds a polarized cell. Nat Rev Mol Cell Biol 9:860–873.
107. Lingor P, Koch JC, Tonges L, Bahr M. 2012. Axonal degeneration as a therapeutic target in the CNS. Cell Tissue Res 349:289–311.
108. Liu R, Dang W, Du Y, Zhou Q, Jiao K, Liu Z. 2015. SIRT2 is involved in the modulation of depressive behaviors. Sci Rep 5:8415.
109. Lucas FR, Goold RG, Gordon-Weeks PR, Salinas PC. 1998. Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J Cell Sci 111:1351–1361.
110. Ludin B, Ashbridge K, Fünfschilling U, Matus A. 1996. Functional analysis of the MAP2 repeat domain. J Cell Sci 109:91–99.
111. Magiera MM, Janke C. 2014. Post-translational modifications of tubulin. Curr Biol 24:R351–354.
112. Marley A, von Zastrow M. 2012. A simple cell-based assay reveals that diverse neuropsychiatric risk genes converge on primary cilia. PloS One 7:e46647.
113. Marx CE, Jarskog LF, Lauder JM, Gilmore JH, Lieberman JA, Morrow AL. 2000. Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia. Brain Res 871:104–112.
114. Matsunaga W, Miyata S, Kiyohara T. 1999. Redistribution of MAP2 immunoreactivity in the neurohypophysial astrocytes of adult rats during dehydration. Brain Res 829:7–17.
115. Matten WT, Aubry M, West J, Maness PF. 1990. Tubulin is phosphorylated at tyrosine by pp60c-src in nerve growth cone membranes. J Cell Biol 111:1959–1970.
116. Matus A. 1988. Microtubule-associated proteins: their potential role in determining neuronal morphology. Annu Rev Neurosci 11:29–44.
117. Mayo JC, Sainz RM, Tan DX, Antolin I, Rodriguez C, Reiter RJ. 2005. Melatonin and Parkinson's disease. Endocrine 27:169–178.
118. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, Perkins DO, Dickel DE, Kusenda M, Krastoshevsky O, et al. 2009. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 41:1223–1227.
119. McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, Nasca C. 2015. Mechanisms of stress in the brain. Nat Neurosci 18(10), 1353–1363.
120. McMurray CT. 2000. Neurodegeneration: diseases of the cytoskeleton? Cell Death Differ 7:861–865.
121. Melendez J, Maldonado V, Ortega A. 1996. Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells. Neurochem Res 21:653–658.
122. Mochizuki H, Toda H, Ando M, Kurusu M, Tomoda T, Furukubo-Tokunaga K. 2011. Unc-51/ATG1 controls axonal and dendritic development via kinesin-mediated vesicle transport in the Drosophila brain. PLoS One 6:e19632.
123. Moehle MS, Luduena RF, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE. 2012. Regional differences in expression of?? -tubulin isoforms in schizophrenia. Schizophr Res 135:181–186.
124. Mohri H. 1968. Amino-acid composition of “Tubulin” constituting microtubules of sperm flagella. Nature 217:1053–1054.
125. Murakami K, Fellous A, Baulieu EE, Robel P. 2000. Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly. Proc Natl Acad Sci U S A 97:3579–3584.
126. Nogales E, Wolf SG, Downing KH. 1998. Structure of the alpha beta tubulin dimer by electron crystallography. Nature 391:199–203.
127. O'Leary O, Nolan Y. 2015. Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders. CNS Drugs 29:1–15.
128. Ozer RS, Halpain S. 2000. Phosphorylation-dependent localization of microtubule-associated protein MAP2c to the actin cytoskeleton. Mol Biol Cell 11:3573–3587.
129. Parésys L, Hoffmann K, Froger N, Bianchi M, Villey I, Baulieu EE, Fuchs E. 2015. Effects of the Synthetic Neurosteroid: 3β-Methoxypregnenolone (MAP4343) on Behavioral and Physiological Alterations Provoked by Chronic Psychosocial Stress in Tree Shrews. Int J Neuropsychopharmacol 17:205–211
130. Pavlowsky A, Zanchi A, Pallotto M, Giustetto M, Chelly J, Sala C, Billuart P. 2010. Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions. Commun Integr Biol 3:245–247.
131. Pedrotti B, Islam K. 1997. Estramustine phosphate but not estramustine inhibits the interaction of microtubule associated protein 2 (MAP2) with actin filaments. FEBS Lett 403:123–126.
132. Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM. 2011. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14:285–293.
133. Perdiz D, Mackeh R, Poüs C, Baillet A. 2011. The ins and outs of tubulin acetylation: more than just a post-translational modification? Cell Signal 23:763–771.
134. Picchioni MM, Murray RM. 2007. Schizophrenia. BMJ (Clinical research ed.) 335:91–95.
135. Piubelli C, Carboni L, Becchi S, Mathé a, Domenici E. 2011. Regulation of cytoskeleton machinery, neurogenesis and energy metabolism pathways in a rat gene-environment model of depression revealed by proteomic analysis. Neuroscience 176:349–380.
136. Plassart-Schiess E, Baulieu EE. 2001. Neurosteroids: recent findings. Brain Res Rev 37:133–140.
137. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JTJ, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, et al. 2004. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684–697.
138. Prieto-Gomez B, Velazquez-Paniagua M, Cisneros LO, Reyes-Vazquez C, Jimenez-Trejo F, Reyes ME, Mendoza-Torreblanca J, Gutierrez-Ospina G. 2008. Melatonin attenuates the decrement of dendritic protein MAP-2 immuno-staining in the hippocampal CA1 and CA3 fields of the aging male rat. Neurosci Lett 448:56–61.
139. Quach TT, Honnorat J, Kolattukudy PE, Khanna R, Duchemin AM. 2015. CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases. Mol Psychiatry 20:1037–1045.
140. Quinlan EM, Halpain S. 1996. Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors. Neuron 16:357–368.
141. Rajkumar AP, Christensen JH, Mattheisen M, Jacobsen I, Bache I, Pallesen J, Grove J, Qvist P, McQuillin A, Gurling HM, et al. 2014. Analysis of t(9;17)(q33.2;q25.3) chromosomal breakpoint regions and genetic association reveals novel candidate genes for bipolar disorder. Bipolar Disord 17:205–211.
142. Reimer U, Scherer G, Drewello M, Kruber S, Schutkowski M, Fischer G. 1998. Side-chain effects on peptidyl-prolyl cis/trans isomerisation. J Mol Biol 279:449–460.
143. Rioux L, Nissanov J, Lauber K, Bilker WB, Arnold SE. 2003. Distribution of microtubule-associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia. Am J Psychiatry 160(1):149–155.
144. Roberts E, Bologa L, Flood JF, Smith GE. 1987. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res 406:357–362.
145. Robison AJ. 2014. Emerging role of CaMKII in neuropsychiatric disease. Trends Neurosci 37:653–662.
146. Rosenblat JD, Brietzke E, Mansur RB, Maruschak NA, Lee Y, McIntyre RS. 2015. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J Affect Disord 188:149–159.
147. Sanchez C, Tompa P, Szucs K, Friedrich P, Avila J. 1996. Phosphorylation and dephosphorylation in the proline-rich C-terminal domain of microtubule-associated protein 2. Eur J Biochem 241:765–771.
148. Schmitt A, Malchow B, Hasan A, Falkai P. 2014. The impact of environmental factors in severe psychiatric disorders. Front Neurosci 8:19.
149. Schoenfeld TA, McKerracher L, Obar R, Vallee RB. 1989. MAP 1A and MAP 1B are structurally related microtubule associated proteins with distinct developmental patterns in the CNS. J Neurosci 9:1712–1730.
150. Shelton MA, Newman JT, Gu H, Sampson AR, Fish KN, MacDonald ML, Moyer CE, DiBitetto JV, Dorph-Petersen KA, Penzes P, et al. 2015. Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia. Biol Psychiatry 78:374–385.
151. Shimizu H, Iwayama Y, Yamada K, Toyota T, Minabe Y, Nakamura K, Nakajima M, Hattori E, Mori N, Osumi N, et al. 2006. Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia. Schizophr Res 84:244–252.
152. Shoichet SA, Duprez L, Hagens O, Waetzig V, Menzel C, Herdegen T, Schweiger S, Dan B, Vamos E, Ropers HH, et al. 2006. Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy. Hum Genet 118:559–567.
153. Sim AT. 1991. The regulation and function of protein phosphatases in the brain. Mol Neurobiol 5:229–246.
154. Soetanto A, Wilson RS, Talbot K, Un A, Schneider JA, Sobiesk M, Kelly J, Leurgans S, Bennett DA, Arnold SE. 2010. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry 67:448–457.
155. Solis-Chagoyan H, Calixto E, Figueroa A, Montano LM, Berlanga C, Rodriguez-Verdugo MS, Romo F, Jimenez M, Gurrola CZ, Riquelme A, et al. 2013. Microtubule organization and L-type voltage-activated calcium current in olfactory neuronal cells obtained from patients with schizophrenia and bipolar disorder. Schizophr Res 143:384–389.
156. Somenarain L, Jones LB. 2010. A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea. J Psychiatr Res 44:694–699.
157. Sponne I, Fifre A, Drouet B, Klein C, Koziel V, Pincon-Raymond M, Olivier JL, Chambaz J, Pillot T. 2003. Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. J Biol Chem 278:3437–3445.
158. Song JS, Yang SD. 1995. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain. J Protein Chem 14:95–105.
159. Szunyogh S, Oláh J, Szénási T, Szabó A, Ovádi J. 2015. Targeting the interface of the pathological complex of α-synuclein and TPPP/p25. Biochim Biophys Acta 1852:2653–2661.
160. Tararuk T, Ostman N, Li W, Björkblom B, Padzik A, Zdrojewska J, Hongisto V, Herdegen T, Konopka W, Courtney MJ, et al. 2006. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J Cell Biol 173:265–277.
161. Taya S, Shinoda T, Tsuboi D, Asaki J, Nagai K, Hikita T, Kuroda S, Kuroda K, Shimizu M, Hirotsune S, et al. 2007. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci 27:15–26.
162. Teng J, Takei Y, Harada A, Nakata T, Chen J, Hirokawa N. 2001. Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization. J Cell Biol 155:65–76.
163. Tirián L, Hlavanda E, Oláh J, Horváth I, Orosz F, Szabó B, Kovács J, Szabad J, Ovádi J. 2003. TPPP/p25 promotes tubulin assemblies and blocks mitotic spindle formation. Proc Natl Acad Sci U S A 100:13976–13981.
164. Tischfield MA, Engle EC. 2010. Distinct alpha- and beta-tubulin isotypes are required for the positioning, differentiation and survival of neurons: new support for the 'multi-tubulin' hypothesis. Biosci Rep 30:319–330.
165. Tsutsui K, Ukena K, Usui M, Sakamoto H, Takase M. 2000. Novel brain function: biosynthesis and actions of neurosteroids in neurons. Neurosci Res 36:261–273.
166. Tsuyama S, Terayama Y, Matsuyama S. 1987. Numerous phosphates of microtubule-associated protein 2 in living rat brain. J Biol Chem 262:10886–92.
167. van Veen T, Goeman JJ, Monajemi R, Wardenaar KJ, Hartman CA, Snieder H, Nolte IM, Penninx BW, Zitman FG. 2012. Different gene sets contribute to different symptom dimensions of depression and anxiety. Am J Med Genet B 159B:519–528.
168. Varidaki A, Mohammad H, Coffey ET. 2016. Molecular Mechanisms of Depression. Systems Neurosience in Depression. In: Frodl T, editor: Elsevier, Academic Press, London, UK, Elsevier. 143–163.
169. Verhey KJ, Gaertig J. 2007. The tubulin code. Cell Cycle (Georgetown, Tex.) 6:2152–2160.
170. Villarroel-Campos D, Gonzalez-Billault C. 2014. The MAP1B case: an old MAP that is new again. Dev Neurobiol 74:953–971.
171. Vincze O, Tökési N, Oláh J, Hlavanda E, Zotter A, Horváth I, Lehotzky A, Tirián L, Medzihradszky KF, Kovács J, et al. 2006. Tubulin polymerization promoting proteins (TPPPs): members of a new family with distinct structures and functions. Biochemistry 45:13818–13826.
172. Wang X, Nadarajah B, Robinson AC, McColl BW, Jin JW, Dajas-Bailador F, Boot-Handford RP, Tournier C. 2007. Targeted deletion of the mitogen-activated protein kinase kinase 4 gene in the nervous system causes severe brain developmental defects and premature death. Mol Cell Biol 27:7935–7946.
173. Weder N, Zhang H, Jensen K, Yang BZ, Simen A, Jackowski A, Lipschitz D, Douglas-Palumberi H, Ge M, Perepletchikova F, et al. 2014. Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry. J Am Acad Child Adolesc Psychiatry 53:417–424.
174. Weisshaar B, Doll T, Matus A. 1992. Reorganisation of the microtubular cytoskeleton by embryonic microtubule-associated protein 2 (MAP2c). Development 116:1151–1161.
175. Wells WA. 2005. The discovery of Tubulin. J Cell Biol 169:552.
176. Wera S, Hemmings BA. 1995. Serine/threonine protein phosphatases. Biochem J 311:17–29.
177. Westerlund N, Zdrojewska J, Padzik A, Komulainen E, Björkblom B, Rannikko E, Tararuk T, Garcia-Frigola C, Sandholm J, Nguyen L, et al. 2011. Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rate. Nat Neurosci 14:305–313.
178. Wille H, Mandelkow EM, Dingus J, Vallee RB, Binder LI, Mandelkow E. 1992. Domain structure and antiparallel dimers of microtubule-associated protein 2 (MAP2). J Struct Biol 108:49–61.
179. Winchester CL, Ohzeki H, Vouyiouklis DA, Thompson R, Penninger JM, Yamagami K, Norrie JD, Hunter R, Pratt JA, Morris BJ. 2012. Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia. Hum Mol Genet 21:4910–4921.
180. Witte H, Bradke F. 2008. The role of the cytoskeleton during neuronal polarization. Curr Opin Neurobiol 18:479–487.
181. Wong GT, Chang RC, Law AC. 2013. A breach in the scaffold: the possible role of cytoskeleton dysfunction in the pathogenesis of major depression. Ageing Res Rev 12:67–75.
182. Woolf NJ. 2009. Bionic Microtubules: Potential Applications to MultipleNeurological and Neuropsychiatric Diseases. J Nanoneurosci 1:85–94.
183. Yamauchi T, Hitoshi F. 1982. Phosphorylation of microtubule-associated protein 2 by calmodulin-dependent protein kinase (kinase II) which occurs only in the brain tissues. Biochem Biophys Res Commun 109(3):975–981.
184. Yamamoto H. et al. 1985. Ca2+, calmodulin-dependent regulation of microtubule formation via phosphorylation of microtubule-associated protein 2, τ factor, and tubulin, and comparison with the cyclic AMP-dependent phosphorylation. J Neurochem 44(3):759–768.
185. Yang C, Wang G, Wang H, Liu Z, Wang X. 2009. Cytoskeletal alterations in rat hippocampus following chronic unpredictable mild stress and re-exposure to acute and chronic unpredictable mild stress. Behav Brain Res 205:518–524.
186. Yu I, Garnham CP, Roll-Mecak A. 2015. Writing and Reading the Tubulin Code. J Biol Chem 290:jbc.R115.637447–jbc.R115.637447.
187. Zhang F, Su B, Wang C, Siedlak SL, Mondragon-Rodriguez S, Lee H-G, Wang X, Perry G, Zhu X. 2015. Posttranslational modifications of α-tubulin in alzheimer disease. Transl Neurodegener 4:9.